Y H Ding1, T Tieu2, D F Kallmes1. 1. From the Neuroradiology Research Laboratory (Y.H.D., D.F.K.), Department of Radiology, Mayo Clinic, Rochester, Minnesota. 2. MicroVention (T.T.), Tustin, California. tai.tieu@microvention.com.
Abstract
BACKGROUND AND PURPOSE: The development of new generation flow-diverting devices will improve the result of flow diversion in challenging aneurysms. The Flow-Redirection Endoluminal Device system is a dual-layer flow-diversion device. The purpose of this study was to evaluate the effectiveness and safety of the Flow-Redirection Endoluminal Device in a sidewall aneurysm model and in the abdominal aorta in rabbits. MATERIALS AND METHODS: Single Flow-Redirection Endoluminal Devices were implanted in the right common carotid artery across sidewall, vein-pouch aneurysms and within the abdominal aorta in 22 New Zealand white rabbits and followed for 1 (n = 5), 3 (n = 5), 6 (n = 4), and 12 months (n = 8). Aneurysm occlusion was graded on a 3-point scale based on digital subtraction angiography (grade I, complete occlusion; grade II, near-complete occlusion; and grade III, incomplete occlusion). Toluidine blue and basic fuchsin staining was used for the evaluation of thrombus organization within the aneurysm and neck coverage with neointima. A scanning electron microscope was used for confirmation of the patency of branch vessels along with DSA. RESULTS: Grades I and II occlusion rates were noted in 19 (86%) and 3 (14%) aneurysms, respectively, which indicated a 100% rate of complete or near-complete occlusion. No parent artery and branch artery occlusion was shown on DSA. Histologic images indicated partial or complete intraluminal thrombus organization and neointima coverage across the aneurysm neck. A scanning electron microscope indicated that all the vessel branches along the length of the device remained patent. CONCLUSIONS: The Flow-Redirection Endoluminal Device in experimental aneurysms demonstrated high rates of progressive and complete aneurysm occlusion while preserving the patency of branch vessels.
BACKGROUND AND PURPOSE: The development of new generation flow-diverting devices will improve the result of flow diversion in challenging aneurysms. The Flow-Redirection Endoluminal Device system is a dual-layer flow-diversion device. The purpose of this study was to evaluate the effectiveness and safety of the Flow-Redirection Endoluminal Device in a sidewall aneurysm model and in the abdominal aorta in rabbits. MATERIALS AND METHODS: Single Flow-Redirection Endoluminal Devices were implanted in the right common carotid artery across sidewall, vein-pouch aneurysms and within the abdominal aorta in 22 New Zealand white rabbits and followed for 1 (n = 5), 3 (n = 5), 6 (n = 4), and 12 months (n = 8). Aneurysm occlusion was graded on a 3-point scale based on digital subtraction angiography (grade I, complete occlusion; grade II, near-complete occlusion; and grade III, incomplete occlusion). Toluidine blue and basic fuchsin staining was used for the evaluation of thrombus organization within the aneurysm and neck coverage with neointima. A scanning electron microscope was used for confirmation of the patency of branch vessels along with DSA. RESULTS: Grades I and II occlusion rates were noted in 19 (86%) and 3 (14%) aneurysms, respectively, which indicated a 100% rate of complete or near-complete occlusion. No parent artery and branch artery occlusion was shown on DSA. Histologic images indicated partial or complete intraluminal thrombus organization and neointima coverage across the aneurysm neck. A scanning electron microscope indicated that all the vessel branches along the length of the device remained patent. CONCLUSIONS: The Flow-Redirection Endoluminal Device in experimental aneurysms demonstrated high rates of progressive and complete aneurysm occlusion while preserving the patency of branch vessels.
Authors: Lee A Tan; Kiffon M Keigher; Stephan A Munich; Roham Moftakhar; Demetrius K Lopes Journal: J Neurointerv Surg Date: 2014-02-19 Impact factor: 5.836
Authors: L Cirillo; M Leonardi; M Dall'olio; C Princiotta; A Stafa; L Simonetti; F Toni; R Agati Journal: Interv Neuroradiol Date: 2012-12-03 Impact factor: 1.610
Authors: David F Kallmes; Yong Hong Ding; Daying Dai; Ramanathan Kadirvel; Debra A Lewis; Harry J Cloft Journal: Stroke Date: 2007-07-05 Impact factor: 7.914
Authors: Giorgio Cattaneo; Christoph Brochhausen; Ruben Mühl-Benninghaus; Frederik Fries; Mara Kießling; Toshiki Tomori; Stefanie Krajewski; Andreas Simgen; Sabina Bauer; Natascha Hey; Eduard Brynda; Johanka Taborska; Tomáš Riedel; Wolfgang Reith Journal: Cardiovasc Intervent Radiol Date: 2021-12-16 Impact factor: 2.740
Authors: Cameron G McDougall; Orlando Diaz; Alan Boulos; Adnan H Siddiqui; Justin Caplan; Johanna T Fifi; Aquilla S Turk; Yasha Kayan; Pascal Jabbour; Louis J Kim; Steven W Hetts; Daniel L Cooke; Christopher F Dowd Journal: J Neurointerv Surg Date: 2021-07-19 Impact factor: 8.572